Pharmaceutical Technology

MAY 2, 2023

IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000. Patients and healthcare facilities across markets often experience difficulties getting these agents reimbursed. Cost-related unmet needs also scored highly.

Immunization 52

Immunization Vaccines 52

pharmaphorum

NOVEMBER 27, 2022

Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication. While these facilities may not yet exist, the principles can be adopted by any pharmaceutical lab by putting more emphasis on agility to help cut down on safety stock.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Labelling 105

Labelling Data Entry Communication FDA 105

pharmaphorum

DECEMBER 2, 2020

. “The ‘first industrial war’ involved drug producers as much as weapons manufacturers” Erhart died in 1891, and Pfizer in 1906, leaving a company of around 200 employees in the hands of Emil Pfizer, who served as president until the 1940s, the last member of the Pfizer family to be involved in managing the company.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

European Pharmaceutical Review

DECEMBER 27, 2023

Considerations for in-house CAR facilities When establishing a point-of-care CAR facility, there are several initial considerations that must be addressed. First, leukapheresis – the first step in producing CAR T cells – is usually carried out in transplant departments or processing facilities. Journal of Clinical Oncology.

Adverse Reactions 83

Adverse Reactions Immunization Medical Schools Chemotherapy 83

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. To overcome manufacturing issues, in December 2021, Novo Nordisk announced its plans to build three new manufacturing facilities.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. To overcome manufacturing issues, in December 2021, Novo Nordisk announced its plans to build three new manufacturing facilities.

Insurance 98

Insurance Labelling Communication FDA 98